Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6304 of 6351
-
COVID infection study in hospital staff withdrawn before start
Knowledge-focused CancelledThe aim of the study is to determine the incidence o of SARS-cov2 infection among health care workers highly exposed to covid 19 during 10 weeks et to analyze the determinants of their occupational and environmental exposure. Every 14 days, we performed SARS-Cov2 RT- PCR, serolog…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Generic numbing cream put to the test in healthy volunteers
Knowledge-focused CompletedThe test formulation (Lidocaine and Prilocaine Cream, Haisco Pharmaceutical Group Co., Ltd.) and the reference formulation (EMLA®, AstraZeneca) were applied to healthy adult subjects under fasting conditions to evaluate the bioequivalence and safety of the two formulations
Phase 1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Brain training for dizziness: study pulled before it began
Symptom relief CancelledIn this study the investigators propose to apply cognitive training, which has been largely used in the realm of age-related cognitive decline, dementia, and Alzheimer's disease, in a novel clinical context to individuals with vestibular impairment. In prior work the investigator…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
COVID prevention trial for seniors pulled before it started
Prevention CancelledOlder adults are at the highest risk of complications and severe illness for 2019-nCoV infections. Hydroxychloroquine (HCQ), an emerging chemoprophylaxis, which holds clinical and mechanistic plausibility, will help to reduce disease incidence and mitigate disease severity across…
Phase 3 • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Prevention
Last updated Jun 26, 2026 17:03 UTC
-
Scientists track Venglustat's journey through healthy men
Knowledge-focused CompletedPrimary Objectives: * To determine the excretion balance and systemic exposure of radioactivity after oral administration of \[14C\]-venglustat. * To determine the pharmacokinetics (PK) of venglustat and its contribution to the overall exposure of radioactivity. * To determine t…
Phase 1 • Sponsor: Genzyme, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:21 UTC
-
Tiny study on drug monitoring in scleroderma ends early
Knowledge-focused Stopped earlyTo define a target value of AUC MPA to improve the modified Rodnan score and / or respiratory impairment (DLCO or FVC) at one year in patients receiving MMF for the treatment of diffuse cutaneous or interstitial lung damage of systemic sclerosis.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:32 UTC
-
French ear infection questionnaire study pulled before it began
Knowledge-focused CancelledThe World Health Organization estimates that chronic otitis media could reach between 65 and 350 million people worldwide and thus be an important cause of medical consultation and prescription drugs. The medical care of chronic otitis is difficult, despite several medical and s…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
MS drug interaction study: will common meds change tolebrutinib levels?
Knowledge-focused CompletedThis is a Phase 1, single-center, open-label, non-randomized study to assess the effects of CYP2C8 inhibition using gemfibrozil, and CYP3A4 and CYP2C8 induction using rifampicin on the pharmacokinetics of SAR442168 in healthy male participants aged 18 to 45 years.
Phase 1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:32 UTC
-
COVID-19 drug study pulled before it even started
Disease control CancelledStudying the efficacy of IL-6 inhibition utilizing single or double dose subcutaneous administration of Sarilumab in patients with severe respiratory distress caused by COVID19 regarding improvement in oxygen demands and other clinical outcomes.
Phase 2 • Sponsor: BayCare Health System • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
MRI crystal ball for rectal cancer? study pulled before start
Knowledge-focused CancelledThis retrospective study aims to investigate whether initial imaging characteristics of rectal cancer on Magnetic Resonance Imaging (MRI) correlate with the underlying tumour pathology and oncological outcomes such as response to treatment. Using radiomic features, calculated usi…
Sponsor: NHS Grampian • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Fetal lung MRI hopes to spot breathing trouble before birth
Diagnosis CancelledThe objective is to evaluate the quality of the response to the Blood Oxygen Level Dependent effect in fetuses with diaphragmatic hernias and abdominal wall malformations and to correlate with postnatal respiratory outcome. Pulmonary involvement is a constant in diaphragmatic her…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Heart drug trial pulled before it even started
Symptom relief CancelledThe objectives of the study are to assess the safety, tolerability, and potential efficacy of IMB-1018972 on patients with refractory angina. Study will assess functional capacity employing a modified Bruce Protocol treadmill ETT, patient reports of angina symptoms via an electro…
Phase 2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Bowel prep boost? study pulled before starting
Knowledge-focused CancelledThis is a multicenter interrupted-time series study. The study will include patients between the age of 18-85 year old, both males and females, who are scheduled for inpatient colonoscopy procedure. The study will be divided into two phases: The initial phase will be a prospect…
Sponsor: Henry Ford Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Lockdown and the mind: study on Quarantine's toll on psychiatric patients never got off the ground
Knowledge-focused CancelledQuarantine related to the Covid-19 pandemic has begun on the 03/17/2020 in France. Quarantine has already be linked to pejorative effects on mental health. In this study, we aim to evaluated PTSD symptoms of patients already followed by a psychiatrist during quarantine, one month…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Healthy volunteers needed to unlock platelet secrets
Knowledge-focused Recruiting nowThis is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Remote monitoring for COVID-19 in nursing homes: study withdrawn
Knowledge-focused CancelledSince the last 3 months the world copes with the novel coronavirus disease : Covid-19 emerged in China in the end of 2019. WHO declared the pandemic situation as a Public Health Emergency around the world on January 2020. Firsts studies emphasized on higher risk to older adults …
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Eczema cream put to the light test: will it cause skin reactions?
Knowledge-focused CompletedThis is a single-centre, randomised, vehicle-controlled, double-blind, within-subject comparison phase 1 clinical trial. The trial is designed to find out if delgocitinib cream can cause skin irritation after light exposure in people with healthy skin.
Phase 1 • Sponsor: LEO Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Withdrawn plasma study leaves COVID-19 pneumonia treatment question unanswered
Disease control CancelledCurrently there are no proven treatment option for COVID-19. Human convalescent plasma is an option for COVID-19 treatment and could be available from people who have recovered and can donate plasma.
Phase 1 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Brain zaps reveal how we focus on feelings
Knowledge-focused CompletedThe goal of this clinical trial is to examine the differential effect of continuous TBS (cTBS) over the left and right dorsolateral prefrontal cortex (DLPFC) on the facilitation of attention towards emotional (i.e., pleasant and distress-ing) versus neutral stimuli in healthy you…
Sponsor: University of Cyprus • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Hydroxychloroquine trial for COVID-19 fizzles out
Disease control Stopped earlyPrimary Objective: To assess the effect of hydroxychloroquine versus placebo on nasopharyngeal SARS-CoV-2 viral load in outpatient adults with COVID-19 Secondary Objectives: * To assess the effect of hydroxychloroquine versus placebo on clinical signs and symptoms and progress…
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC